Sun Pharma Corporate Overview

EBITDA Trend In INR Billion Sales 303 261 287 323 331 % of Sales 26.9% 28.0% 27.4% 28.6% 26.2% 16.2% 20.7% 21.0% 20.8% 19.7% 27.9% 28.6% 31.0% 31.1% 31.8% 29.0% 24.5% 19.9% 20.7% 20.0% FY17 FY18 FY19 FY20 FY21 EBITDA Other Expenditure Personnel Costs Material Costs © Sun Pharmaceutical Industries Limited. All Rights Reserved. SUN PHARMA 45

View entire presentation